These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 1726729)

  • 1. Update on calcium antagonists in cerebrovascular diseases.
    Toni D; Frontoni M; Argentino C; Sacchetti ML; De Michele M; Fieschi C
    J Cardiovasc Pharmacol; 1991; 18 Suppl 8():S10-4. PubMed ID: 1726729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From pharmacological promises to controlled clinical trials to meta-analysis and back: the case of nimodipine in cerebrovascular disorders.
    Di Mascio R; Marchioli R; Tognoni G
    Clin Trials Metaanal; 1994 Apr; 29(1):57-79. PubMed ID: 10150186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical experiences with nimodipine in cerebral ischemia.
    Kakarieka A; Schakel EH; Fritze J
    J Neural Transm Suppl; 1994; 43():13-21. PubMed ID: 7884395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nimodipine and its use in cerebrovascular disease: evidence from recent preclinical and controlled clinical studies.
    Tomassoni D; Lanari A; Silvestrelli G; Traini E; Amenta F
    Clin Exp Hypertens; 2008 Nov; 30(8):744-66. PubMed ID: 19021025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
    Schmid-Elsaesser R; Kunz M; Zausinger S; Prueckner S; Briegel J; Steiger HJ
    Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium antagonists in the management of subarachnoid haemorrhage.
    Robinson MJ; Teasdale GM
    Cerebrovasc Brain Metab Rev; 1990; 2(3):205-26. PubMed ID: 2223432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vascular and neuronal mechanisms of calcium antagonists. Significance in neurological therapy].
    Govoni S; Trabucchi M; Battaini F; Magnoni MS; Paoletti R
    Minerva Med; 1986 Jun; 77(24):1053-8. PubMed ID: 3725133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New aspects of calcium antagonists for treatment of cerebrovascular disease.
    Hennerici MG
    J Cardiovasc Pharmacol; 1991; 18 Suppl 10():S59-63. PubMed ID: 1725006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of calcium channel blockers in acute ischemic cerebrovascular disease.
    Dalal PM; Dalal KP
    J Assoc Physicians India; 1995 Jun; 43(6):394-7. PubMed ID: 8906943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective properties of calcium-channel blockers.
    Zornow MH; Prough DS
    New Horiz; 1996 Feb; 4(1):107-14. PubMed ID: 8689265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of calcium channel blockers in acute ischemic cerebrovascular disease.
    Sood AK; Dua A; Mahajan A; Arora S
    J Assoc Physicians India; 1996 Jan; 44(1):70. PubMed ID: 8773106
    [No Abstract]   [Full Text] [Related]  

  • 12. Nimodipine in subarachnoid hemorrhage.
    DiPalma JR
    Am Fam Physician; 1989 Dec; 40(6):143-5. PubMed ID: 2686374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium antagonists in the management of patients with aneurysmal subarachnoid hemorrhage: a review.
    Adams HP
    Angiology; 1990 Nov; 41(11 Pt 2):1010-6. PubMed ID: 2248423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicardipine use in cerebrovascular disease: a review of controlled clinical studies.
    Amenta F; Lanari A; Mignini F; Silvestrelli G; Traini E; Tomassoni D
    J Neurol Sci; 2009 Aug; 283(1-2):219-23. PubMed ID: 19303080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prospective pharmacologic treatments for subarachnoid hemorrhage].
    Carteri A; Billeci D; Copetti E
    Minerva Anestesiol; 1998 May; 64(5):257-9. PubMed ID: 9773673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Best evidence topic reports. Does nimodipine reduce mortality and secondary ischaemic events after subarachnoid haemorrhage?
    Brown G; Carley S
    Emerg Med J; 2004 May; 21(3):333. PubMed ID: 15107373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of calcium antagonists on the cerebral circulation.
    Gelmers HJ
    Am J Cardiol; 1987 Jan; 59(3):173B-176B. PubMed ID: 2433932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized double-blind controlled study of nimodipine in acute cerebral ischemic stroke.
    Nag D; Garg RK; Varma M
    Indian J Physiol Pharmacol; 1998 Oct; 42(4):555-8. PubMed ID: 10874361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The challenge of blood pressure management in neurologic emergencies.
    Talbert RL
    Pharmacotherapy; 2006 Aug; 26(8 Pt 2):123S-130S. PubMed ID: 16863478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Calcium channel blockers in therapy of neurologic diseases].
    Wessely P; Wöber-Bingöl C
    Wien Med Wochenschr; 1993; 143(19-20):514-8. PubMed ID: 8135034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.